SCHEMBL30658000

SCHEMBL30658000

COCOc1ccccc1-c1cc2[nH]c(C3CN(C(=O)OC(C)(C)C)C3)cc2nn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMARCA2 P51531 2/20 0.38
▸ SMARCA4 P51532 2/20 0.38
▸ PBRM1 Q86U86 2/20 0.38
▸ CCNT1 O60563 2/20 0.38
▸ CDK9 P50750 2/20 0.38
▸ BACE1 P56817 5/20 0.37
▸ BACE2 Q9Y5Z0 2/20 0.37
▸ CACNB4 O00305 1/20 0.36
▸ CACNA1A O00555 1/20 0.36
▸ CACNA1G O43497 1/20 0.36
▸ CACNG3 O60359 1/20 0.36
▸ CACNA1F O60840 1/20 0.36
▸ CACNA1H O95180 1/20 0.36
▸ CACNB3 P54284 1/20 0.36
▸ CACNA2D1 P54289 1/20 0.36
▸ CACNG7 P62955 1/20 0.36
▸ CACNA1B Q00975 1/20 0.36
▸ CACNA1D Q01668 1/20 0.36
▸ CACNB1 Q02641 1/20 0.36
▸ CACNG1 Q06432 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26654056 1.00 SMARCA2 (0.38) SMARCA2SMARCA4PBRM1CCNT1CDK9
SCHEMBL31505531 0.86 CCNT1 (0.41) SMARCA2SMARCA4PBRM1CCNT1CDK9
SCHEMBL30658056 0.86 SMARCA2 (0.52) SMARCA2SMARCA4PBRM1BACE1BACE2
SCHEMBL26654036 0.86 SMARCA2 (0.52) SMARCA2SMARCA4PBRM1BACE1BACE2
SCHEMBL31505584 0.79 SMARCA2 (0.37) SMARCA2SMARCA4PBRM1CCNT1CDK9
SCHEMBL26654126 0.79 SMARCA2 (0.37) SMARCA2SMARCA4PBRM1CCNT1CDK9
SCHEMBL25215923 0.79 SMARCA2 (0.39) SMARCA2SMARCA4PBRM1CCNT1CDK9
SCHEMBL26654083 0.77 SMARCA2 (0.55) SMARCA2SMARCA4PBRM1CCNKCDK12
SCHEMBL30658017 0.77 SMARCA2 (0.55) SMARCA2SMARCA4PBRM1CCNKCDK12
SCHEMBL31505633 0.76 TACR1 (0.39) SMARCA2SMARCA4PBRM1CCNT1CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522279-A1 PYRAZINE DERIVATIVES AND USES THEREOF Foghorn Therapeutics Inc. (US) 2025-03-19 — — EP disclosed
WO-2023220134-A1 PYRAZINE DERIVATIVES AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2023-11-16 — — WO disclosed
Send feedback